Login / Signup

Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report.

Brigitte Bader-MeunierAlice HadchouelLaureline BertelootLaura PolivkaVivien BéziatJean-Laurent CasanovaRomain Lévy
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • rheumatoid arthritis
  • idiopathic pulmonary fibrosis
  • replacement therapy
  • smoking cessation